priority review vouchers

Bluebird bio to sell sickle cell FDA voucher for $103 mln if therapy approved
Reuters
Mon, 10/30/23 - 10:23 am
Bluebird Bio
priority review vouchers
sickle cell disease
gene therapy
Sarepta sells FDA priority review voucher to mystery buyer for $102M as prices continue to slip
Fierce Pharma
Thu, 07/6/23 - 11:15 am
Sarepta Therapeutics
priority review vouchers
FDA
Novartis buys priority review voucher from Pharming for discount price of $21M
Fierce Biotech
Thu, 06/1/23 - 11:40 am
Novartis
Pharming
priority review vouchers
Bluebird Bio Sells Priority Review Voucher For $102M, Strengthening Its Financial Position
Benzinga
Wed, 11/30/22 - 10:47 am
Bluebird Bio
priority review vouchers
FDA
Argenx
European pharma group wants to create PRV-like system to spur antibiotics R&D
Endpoints
Sun, 10/2/22 - 07:51 pm
Europe
antimicrobials
R&D
priority review vouchers
Marinus Pharma Shares Up After Deal for Rare Pediatric Disease Priority Review Voucher
Morningstar
Thu, 07/14/22 - 10:49 am
Marinus Pharmaceuticals
priority review vouchers
pediatrics
Novo Nordisk
AbbVie Redeems Priority Review Voucher for Rinvoq Approval
BioSpace
Thu, 06/23/22 - 07:53 pm
AbbVie
Rinvoq
priority review
priority review vouchers
ulcerative colitis
BridgeBio adds another $110M to coffers with voucher sale a day after mega BMS deal
Fierce Biotech
Fri, 05/13/22 - 10:50 am
BridgeBio
priority review vouchers
FDA
Newly acquired Alexion pays $100M for Rhythm's speedy review voucher
Fierce Biotech
Wed, 01/6/21 - 10:54 am
AstraZeneca
Alexion
Rhythm
priority review vouchers
Vifor buys priority review voucher for undisclosed filing
Fierce Biotech
Tue, 02/18/20 - 10:28 am
Vifor
priority review vouchers
FDA
priority review
Fees for Redeeming Priority Review Vouchers Fall to All-Time Low in FY2020
RAPS.org
Mon, 09/30/19 - 10:30 am
FDA
priority review vouchers
AstraZeneca pays Sobi $95M for priority review voucher
Fierce Biotech
Thu, 08/22/19 - 11:57 am
AstraZeneca
FDA
Sobi
priority review vouchers
roxadustat
Everything Old is New Again: FDA Revises its 2014 Rare Pediatric Disease Priority Review Voucher Guidance for Industry
FDA Law Blog
Fri, 08/2/19 - 12:17 am
FDA
priority review
priority review vouchers
pediatric
Priority Review Vouchers And Access To Drugs Targeting Neglected Diseases
Forbes
Mon, 04/22/19 - 10:26 am
priority review vouchers
Rare pediatric PRV program not linked to uptick in new drugs starting trials, study finds
Forbes
Thu, 02/7/19 - 09:54 am
FDA
clinical trials
priority review vouchers
pediatrics
pediatric rare diseases
Priority Review Vouchers Revitalizing Neglected Disease Drug Development
Forbes
Mon, 11/5/18 - 10:01 am
neglected tropical diseases
tropical diseases
FDA
priority review vouchers
Lilly buys Siga's Priority Review voucher gained via smallpox approval
BioCentury
Thu, 11/1/18 - 11:34 am
Eli Lilly
SIGA technologies
FDA
priority review vouchers
FDA adds four tropical diseases to Priority Review voucher program
BioCentury
Sat, 08/25/18 - 09:29 pm
FDA
priority review vouchers
tropical diseases
chikungunya virus
rabies
cryptococcal meningitis
Lassa fever
Sparks sells regulatory fast pass to Jazz for $110M
Biopharma Dive
Mon, 04/30/18 - 09:02 pm
Spark Therapeutics
Jazz Pharmaceuticals
priority review vouchers
Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease
CP Wire
Fri, 03/16/18 - 09:37 am
Abeona Therapeutics
FDA
pediatrics
ABO-202
Rare Pediatric Disease designation
priority review vouchers

Pages